In this retrospective analysis, we established and verified an immune score prediction model based on TP53 mutation status and immunity to improve the accuracy of CRC prognosis, namely, immunoscore, which is a set of differentially expressed genes related to prognosis of CRC. The gene discussed is TP53; the disease is colorectal carcinoma.